Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 4.89% vs 31.44% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 21.32% vs 58.01% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -97.77% vs 273.96% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 20.11% vs 54.64% in Mar 2024
Compare Profit and Loss Results of Influx Health.
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
104.00
188.00
-84.00
-44.68%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
104.00
188.00
-84.00
-44.68%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
1.00
-1.00
-100.00%
Raw Materials Consumed
63.00
87.00
-24.00
-27.59%
Power & Fuel Cost
1.00
2.00
-1.00
-50.00%
Employee Cost
8.00
12.00
-4.00
-33.33%
Operating Expenses
7.00
6.00
1.00
16.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
30.00
-29.00
-96.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
6.00
-6.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
84.00
155.00
-71.00
-45.81%
Operating Profit (PBDIT) excl Other Income
20.00
33.00
-13.00
-39.39%
Other Income
0.00
13.00
-13.00
-100.00%
Operating Profit (PBDIT)
20.00
47.00
-27.00
-57.45%
Interest
0.00
3.00
-3.00
-100.00%
Profit before Depriciation and Tax
20.00
43.00
-23.00
-53.49%
Depreciation
2.00
2.00
0.00
0.00%
Profit Before Taxation & Exceptional Items
17.00
41.00
-24.00
-58.54%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
17.00
41.00
-24.00
-58.54%
Provision for Tax
4.00
9.00
-5.00
-55.56%
Profit After Tax
13.00
32.00
-19.00
-59.38%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
16.00
162.00
-146.00
-90.12%
Profit Available for appropriations
29.00
195.00
-166.00
-85.13%
Appropriations
29.00
195.00
-166.00
-85.13%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
7.36
9.57
-2.21
-23.09%
Profit And Loss - Net Sales
Net Sales 104.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.89% vs 31.44% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.32% vs 58.01% in Mar 2024
Profit And Loss - Interest
Interest 0.01 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -97.77% vs 273.96% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 13.37 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.11% vs 54.64% in Mar 2024






